Prisma Health Midlands
Columbia, South Carolina, 29203, United States
NCT Number: NCT04771741
Orthopedic surgeons frequently prescribe and over-prescribe narcotic pain medications during the postoperative period, despite the ongoing opioid crisis in the United States. While opioid-free multimodal pathways have shown promising results, there remains a lack of published literature evaluating opiate-free multimodal pain protocols for elective outpatient foot and ankle surgeries. This study aims to evaluate post-operative pain following the use of an opioid-free pain treatment plan for patients undergoing foot and ankle surgeries.
Looking for future studies?
Notify Me18 year–99 year
All sexes
Observational
Columbia, South Carolina, 29203, United States
Despite the presence and increased understanding of the opioid crisis in the United States, orthopedic surgeons frequently prescribe and over-prescribe narcotic pain medications during the postoperative period. In an effort to minimize narcotic analgesia and its potential side effects, opioid-free multimodal pathways have been developed in many orthopaedic sub-specialties with promising results. There have been early studies reporting the results of non-narcotic protocols during the intra-operative period. Likewise, there have been several studies reporting the results of inpatient non-narcotic pain protocols in select foot and ankle surgeries. However, there remains a lack of published literature evaluating opiate-free multimodal pain protocols for elective outpatient foot and ankle surgeries. Currently, our practice utilizes an opioid-free post-operative pain protocol for patients undergoing elective outpatient foot and ankle surgery. The goal of this study is to evaluate post-operative pain using this opioid-free multimodal pain protocol at days 1,3, and 8 following elective outpatient foot and ankle surgery.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
1,000 mg every 6 hours
Other names: Tylenol
10 mg every 6 hours, days 0-3
Other names: Ketorolac
15 mg once daily, beginning post-op day 4
Other names: Mobic
10 mg every 8 hours
Other names: Flexeril
75 mg every 12 hours
Other names: Pregabalin
Time frame: 2 weeks
Study participants will complete a survey at the 2 week follow-up visit asking yes or no if they were satisfied with the opioid-free pain management protocol.
Time frame: 2 weeks
At 2 weeks, patients will be asked yes or no if they used any additional medications for pain outside of prescriptions that were provided in the opioid-free multimodal pain protocol.
Time frame: 1 day
Study participants will be asked to rate their pain using a Visual Analog Scale (VAS) from 0 (no pain) to 10 (worst pain) at post-operative day 1.
Time frame: 3 days
Study participants will be asked to rate their pain using a Visual Analog Scale (VAS) from 0 (no pain) to 10 (worst pain) at post-operative day 3.
Time frame: 8 days
Study participants will be asked to rate their pain using a Visual Analog Scale (VAS) from 0 (no pain) to 10 (worst pain) at post-operative day 8.
Prisma Health-Midlands
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05412693
Ankle Fractures, Ankle Injuries
Ålesund, Norway
View Trial DetailsNCT05662449
Ankle Fractures, Ankle Injuries
Aberdeen, United Kingdom
View Trial DetailsNCT05494645
Ankle Fractures, Ankle Injuries
Bethlehem, Pennsylvania, United States
View Trial DetailsNCT03809520
Ankle Fractures, Ankle Injuries
Iowa City, Iowa, United States
View Trial Details